FDA begins push to study psychedelics for mental health disorders
Donald Trump
April 24 (UPI) -- The Food and Drug Administration announced regulatory actions Friday to support development of serotonin-2A agonists and related products, including psychedelic drugs. On Saturday, President Donald Trump signed an executive order to speed up research on psychedelic drugs for mental health disorders. "Today's order will ensure that people suffering from debilitating symptoms might finally have a chance to reclaim their lives and lead a happier life," Trump said during the
din zilele anterioare